Recovery and Post-Thaw Assessment of Human Umbilical Cord Blood Cryopreserved as Quality Control Segments and Bulk Samples.


Journal

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
ISSN: 1523-6536
Titre abrégé: Biol Blood Marrow Transplant
Pays: United States
ID NLM: 9600628

Informations de publication

Date de publication:
12 2019
Historique:
received: 17 04 2019
revised: 30 07 2019
accepted: 02 09 2019
pubmed: 10 9 2019
medline: 9 9 2020
entrez: 10 9 2019
Statut: ppublish

Résumé

Quality control (QC) segments conjoined to a bulk sample container are used to evaluate the viability and quality of cryopreserved umbilical cord blood (UCB). Such QC segments are typically attached lengths of sealed tubing that are cooled concurrently with the bulk sample, both containing material from the same donor. QC segments are thawed independently of the bulk sample to assess the quality of the cryopreserved product. In current practice, there is typically post-thaw variation between the QC segment and the bulk sample which if suggestive of inadequate performance, could lead to material being needlessly discarded. In this study, these performance differences were quantified. Two cooling protocols in common use, 1 with and 1 without a "plunge" step to induce ice nucleation, gave equivalent results that maintained the QC segment versus bulk sample differences. Ice nucleated at significantly lower temperatures in the QC segments compared with the bulk samples, a consequence of their lower volume, thereby enhancing damaging osmotic stress. A reduction in total viable cells of approximately 10% was recorded in the QC segments compared with comparable bulk samples. It has been shown that CD45

Identifiants

pubmed: 31499214
pii: S1083-8791(19)30572-5
doi: 10.1016/j.bbmt.2019.09.004
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2447-2453

Informations de copyright

Copyright © 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Auteurs

Peter Kilbride (P)

Asymptote, General Electric Healthcare, Cambridge, United Kingdom. Electronic address: peter.kilbride@ge.com.

Julie Meneghel (J)

Asymptote, General Electric Healthcare, Cambridge, United Kingdom.

Stephen Lamb (S)

Asymptote, General Electric Healthcare, Cambridge, United Kingdom.

John Morris (J)

Asymptote, General Electric Healthcare, Cambridge, United Kingdom.

Jerome Pouzet (J)

General Electric Healthcare, Biosafe SA, Eysins, Switzerland.

Monika Jurgielewicz (M)

Anthony Nolan Cell Therapy Centre, Nottingham Trent University, Nottingham, United Kingdom.

Christopher Leonforte (C)

Anthony Nolan Cell Therapy Centre, Nottingham Trent University, Nottingham, United Kingdom.

Daniel Gibson (D)

Anthony Nolan Cell Therapy Centre, Nottingham Trent University, Nottingham, United Kingdom.

Alejandro Madrigal (A)

Anthony Nolan Cell Therapy Centre, Nottingham Trent University, Nottingham, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH